2.Association between atopy for Platanus Acerifolia pollen and HLA-DRB1 alleles
Ming QI ; Hua WEI ; Qin ZHU ; Aili WANG ; Hua XIONG
Chinese Journal of Clinical Laboratory Science 2006;0(06):-
Objective To develop a PCR-SSP method for detection of HLA-DRB1 alleles in the patients who were hypersensitive to Platanus Acerifolia pollen allergen,and to probe into the association between the atopic subjects to Platanus Acerifolia pollen allergen and HLA-DRB1 alleles.Methods DNA in whole blood was extracted by phenol-chloroform method.Eight pairs of specific primers for alleles were synthesized,and HLA-DRB1*0401,*0402,*0403,*0404,*0405,*0406,*0407,*0408 alleles in 20 atopic patients and 36 healthy individuals of Jiangsu Province with Han nationality were detected by PCR-SSP(polymerase chain reaction-sequence specific primer).Results By optimizing the experimental conditions PCR-SSP methods for detection of the 8 alleles were established and the distributing data of above-mentioned HLA DRB1 were obtained.The frequency of HLA DRB1*0405 and *0406 in the patients group was higher than that of in healthy controls group,while the frequency of HLA DRB1*0402 in the patients group was lower than that in controls.No significant deference for the other 5 alleles was found between the 2 groups.Conclusion HLA-DRB1*0406和*0405 seems to be the likely suspected candidate alleles responsible for susceptibility to Platanus Acerifolia pollen allergen in the atopic patients,while DRB1*0402 might be contribute to the related resistance to the allergen.
3.Development of a Medication Compliance Scale in Patients with Chronic Diseases
Wei-Hua XU ; Qi WANG ; Wei-Xiong LIANG
Chinese Journal of Prevention and Control of Chronic Diseases 2006;0(06):-
Objective To develop a reliable scale for evaluating medication compliance among patients with chronic diseases in China.Methods An initial item pool was generated by literature review,based on the definition of compliance generally accepted in China.The items were then subjected to item selections by using item answer distribution and other four methods,which resulted in a primary scale with 16 items.The reliability and validity of this scale was examined.Results Common factors extracted by factor analysis were well explained,there being a close correspondence between the scale construction and the theoretical construction. Convergent validity with the patients' self-ratings on medication compliance ranged from 0.55 to 0.59,and the correlation coefficient with the score of Morisky questionnaire was 0.58.The Cronbach ?,0 and ? coefficients were 0.717,0.751,0.893 respectively,and test-retest reliability was 0.95.Conclusion The newly developed scale appears reliable and may be a useful tool for measuring drug compliance among patients with chronic diseases,but there are still areas where further improvements may be needed.
4.Effects of ulinastatin on pulmonary and hepatorenal function of elderly patients undergoing resection of esophageal cancer
Xuemei XIONG ; Wei WU ; Mei XIA ; Hua WANG
Chinese Journal of Digestive Surgery 2009;8(5):374-376
Objective To investigate the effects of ulinastatin on pulmonary and hepatorenal function of elderly patients undergoing resection of esophageal cancer. Methods The clinical data of 40 elderly patients with esophageal cancer who had been admitted to Southwest Hospital from January 2005 to January 2008 were retrospectively analyzed. All the patients were randomly divided into control group (n = 20) and ulinastatin group (n = 20) according to random number table. Patients were administered with total parenteral nutrition, and patients in ulinaslatin group were additionally instilled with 4×10~5 U/d of ulinastatin. The levels of PaO_2, PaCO_2, PaO_2/FiO_2, alanine aminotransferase (ALT), aspartate aminotransferase (AST), total bilirubin (Tbil), blood urea nitrogen, creatinine and uric acid were detected preoperatively and at postoperative day 2 and day 6. All the data were analyzed by t-test and chi-square test. Results The levels of PaO_2 and PaO_2/FiO_2 were (87.3±4.2) mm Hg (1 mm Hg =0.133 kPa) and (416±20)mm Hg in ulinastatin group, which were significantly higher than (79.0±4.3)mm Hg and (376±20)mm Hg in control group (t =6.2, 6.2, P <0.05). The levels of ALT, AST and Tbil were (23±7)U/L, (38±8)U/L and (13.4±3.0) μmol/L in ulinastatin group, and (39±8) U/L, (50±9) U/L and (24.5±6.0) μmol/L in control group, with significant difference between the 2 groups (t = 7.0, 4.4, 7.6, P < 0.05). The levels of uric acid, blood urea nitrogen and creatinine were (279±84) μmol/L, (4.1±1.7) mmol/L and (66±12) μmol/L in ulinastatin group, and (386±67)μmol/L, ( 8.9±2.7) mmol/L and (95±38) μmol/L in control group, with significant difference between the 2 groups (t = 4.4, 6.4, 3.3, P < 0.05). The recurrence of complications in ulinastatin group was significantly lower than that in control group (χ~2 = 4.8, P <0.05). Conclusion Postoperative supplementation of ulinastatin and total parenteral nutrition is helpful in improving the pulmonary and hepatorenal function of elderly patients undergoing resection of esophageal cancer.
5.Effect of SMO preservation solution on apoptosis and energy metabolism in canine kidneys during cold storage
Qiu-Cheng HAN ; Xiong-Wei ZHU ; Zhi-Hua ZHOU ;
Chinese Journal of Organ Transplantation 2005;0(10):-
0.05).The activity of Na~+-K~+ ATPase in SMO group was significantly higher than that in HTK group at 72 h(P
6.Problems to pay attention to in taking patient-reported outcomes as clinical outcomes assessment.
Wei-hua XU ; Wei-xiong LIANG ; Qi WANG
Chinese Journal of Integrated Traditional and Western Medicine 2011;31(8):1135-1145
Patient-reported outcomes (PROs) provide clinical researchers with a good means to assess patient-based outcomes. Yet there are still some problems to pay attention to while using PROs as an effectiveness assessment index, including the selection of an appropriate scale of PRO, quality control in PRO data collection, and the interpretations and application ranges of the PRO results.
Outcome Assessment (Health Care)
;
methods
;
Patient Satisfaction
;
Psychometrics
;
Quality Control
7.Primary gastric B-cell lymphoblastic lymphoma: report of a case.
Miao-xia HE ; Xiong-zeng ZHU ; Wei-qiang LIU ; Li-li WU ; Ming-hua ZHU
Chinese Journal of Pathology 2008;37(6):420-421
Adult
;
B-Lymphocytes
;
pathology
;
Female
;
Humans
;
Lymphoma, B-Cell
;
pathology
;
Stomach Neoplasms
;
pathology
8.A comprehensive systematic review with meta-analysis on the relationship of the PON gene and Alzheimer's disease
Yi NIE ; Danyang LUO ; Hua LIU ; Wei LIU ; Li XIONG ; Jifa LONG
Chinese Journal of Nervous and Mental Diseases 2017;43(3):135-140
Objective This study aimed to evaluate the association between the paraoxonase (PON) genes variants and Alzheimer's disease (AD) using systematic review with meta-analysis.Methods Relevant studies were identified by searching English and Chinese databases extensively.Newcastle-Ottawa Scale (NOS) was employed to evaluate the quality of included studies.The odds ratio (OR) was calculated using a random-effects or fixed-effects model.A Q statistic was used to evaluate homogeneity,and fail-safe number,Egger's test and funnel plot were used to assess publication bias.Results A total of 15 studies were included and identified for the current meta-analysis.The NOS scores ranged from 7 to 8,meaning good quality of studies.It was found that the SS genotype of PON2 S311C polymorphism had an significant association with AD in the studied population (OR=0.82,P=0.04).However,there was no significant relationship between other three genetic variants of PON genes and AD.Conclusions Existing evidence indicated that the PON2 S311C polymorphism (SS genotype) was associated with risk of AD in studied population.Future studies with larger sample sizes will be necessary to confirm the present results.
9.Immunigical effect of CpG oligodeoxynucleotide as immune adjuvant of hepatitis B vaccine on pregnant mice and neonatal mice
xin, XIAO ; chun-guang, XU ; ai-hua, XIONG ; jian-wei, JIANG ; yan-fang, XU
Journal of Applied Clinical Pediatrics 1992;0(06):-
0.05); serum HBsAb levels of pregnant mice and neonatal mice in group with CpG-1826 (20 ?g)+hepatitis B vaccine significantly higher than those in group with CpG-1826 (10 ?g, 40 ?g)+ hepatitis B vaccine,hepatitis B vaccine and control respectively(P0.05).Conclusions Combination injection of CpG-1826 20 ?g and hepatitis B vaccine can markedly increase serum antibody levels of pregnant mice and neonatal mice, but don′t affect the survival quantity, the growth and development of neonatal mice.CpG-1826 is an ideal immune adjuvant for neonates with immature immune system during pregnancy.
10.Retrospective study on forty cases of medical legal dispute.
Dai-Hua XU ; Ling HU ; Xian-Wei XIONG
Journal of Forensic Medicine 2009;25(4):279-281
OBJECTIVE:
To analyze the main causes of medical dispute and the main types of medical malpractice. The related problems were discussed in forensic expertise.
METHODS:
Forty cases of medical dispute from 2006 to 2008 in our institute were analyzed retrospectively.
RESULTS:
In 40 cases of medical dispute, city-level hospitals, county-level hospitals, town-level hospitals and private clinics were 11 (27.5%), 24 (60.0%), 2 (5.0%) and 3 (7.5%) cases respectively. The internal medicine departments, surgical departments, gynaecological and obstetric departments, pediatric departments and outpatient center were 16 (40.0%),10 (25.0%), 9 (22.5%), 2 (5.0%) and 3 (7.5%) cases, respectively. The amount of cases from city-level hospitals, county-level hospitals diagnosed by the medical experts as the medical malpractice showed less than that from town-level hospitals and private clinics.
CONCLUSION
The amount of cases of medical dispute from city-level and county-level hospitals were more than that of town-level hospitals. But the amount of cases diagnosed by the medical experts as medical malpractice from city-level and county-level hospitals were less than that of town-level hospital and private clinics.
Expert Testimony
;
Female
;
Forensic Medicine
;
Hospitals, County
;
Hospitals, Urban
;
Humans
;
Male
;
Malpractice/statistics & numerical data*
;
Medical Errors/statistics & numerical data*
;
Retrospective Studies